Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.130
-0.160 (-3.73%)
At close: Aug 24, 2026, 4:00 PM EDT
4.174
+0.044 (1.07%)
After-hours: Aug 24, 2026, 7:30 PM EDT

Ironwood Pharmaceuticals Revenue

Ironwood Pharmaceuticals had revenue of $113.04M in the quarter ending June 30, 2026, with 32.62% growth. This brings the company's revenue in the last twelve months to $389.32M, up 26.19% year-over-year. In the year 2025, Ironwood Pharmaceuticals had annual revenue of $296.15M, down -15.72%.

Revenue (ttm)
$389.32M
Revenue Growth
+26.19%
P/S Ratio
1.78
Revenue / Employee
$3,893,160
Employees
100
Market Cap
682.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025296.15M-55.26M-15.72%
Dec 31, 2024351.41M-91.33M-20.63%
Dec 31, 2023442.74M32.14M7.83%
Dec 31, 2022410.60M-3.16M-0.76%
Dec 31, 2021413.75M24.23M6.22%
Dec 31, 2020389.52M-38.89M-9.08%
Dec 31, 2019428.41M81.77M23.59%
Dec 31, 2018346.64M48.36M16.21%
Dec 31, 2017298.28M24.32M8.88%
Dec 31, 2016273.96M124.40M83.18%
Dec 31, 2015149.56M73.12M95.66%
Dec 31, 201476.44M53.56M234.06%
Dec 31, 201322.88M-127.36M-84.77%
Dec 31, 2012150.25M84.37M128.09%
Dec 31, 201165.87M22.01M50.19%
Dec 31, 201043.86M9.54M27.78%
Dec 31, 200934.32M15.94M86.70%
Dec 31, 200818.38M7.92M75.68%
Dec 31, 200710.46M7.32M233.25%
Dec 31, 20063.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Tilray Brands915.45M
Evotec SE819.47M
Collegium Pharmaceutical808.21M
Pacira BioSciences746.16M
Amphastar Pharmaceuticals730.02M
Evolus316.49M
Canopy Growth206.77M
Kamada191.85M
Revenue Rankings